FDA Clears First Warfarin Sensitivity Test from Nanosphere | GenomeWeb
NEW YORK (GenomeWeb News) - The US Food and Drug Administration this week cleared the first test to detect gene variants in patients that are sensitive to the anticoagulant warfarin. The test is made by Northbrook, Ill.-based Nanosphere.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.